SC 13G/A: SI-BONE, Inc.

AI Summary

SC 13G/A filing by SI-BONE, Inc..

Risk Assessment

Risk Level: low

Key Financial Figures

• $0.0001 — me of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securiti

Filing Documents

• ss3005754_sc13ga.htm (SC 13G/A) — 51KB
• ss3005754_ex99a.htm (EX-99.A) — 7KB
• 0000947871-24-000159.txt ( ) — 59KB

Ownership

Item 4. Ownership: Information with respect to the Reporting Person’s ownership as of December 31, 2023 is incorporated by reference to items (5) - (9) and (11) of the cover page for the Reporting Person.

Ownership

Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the Reporting Person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].

Ownership

Item 6. Ownership of More Than Five Percent on Behalf of Another Person . The Reporting Persons are holding 5.7% of the shares of Common Stock in the aggregate on behalf of other persons who have the right to receive or the power to direct the receipt of dividends from, or proceeds from the sale of, such securities. Advisors and Capital exercise investment and voting power over the shares of Common Stock through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares of Common Stock reported herein. Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not Applicable. Item 8. Identification and Classification of Members of the Group . Not Applicable. Item 9. Notice of Dissolution of Group . Not Applicable. Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a - 11. CUSIP No. 825704109 SCHEDULE 13G Page 7 of 7 Pages

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 14, 2024 OrbiMed Advisors LLC By: /s/ Carl L. Gordon Name: Carl L. Gordon Title: Member OrbiMed Capital LLC By: /s/ Carl L. Gordon Name: Carl L. Gordon Title: Member